Skip to main content
. 2018 Apr 27;8:6681. doi: 10.1038/s41598-018-25035-1

Table 2.

Clinical and laboratory variables at D1 and D7 for the 17 patients, divided in survivors (S, 9 pts) and non-survivors (NS, 8 pts).

D1 D7
S NS S NS
Heart Rate (bpm) 103.5 ± 28.4 106.1 ± 12.8 80.4 ± 11.0 91.1 ± 8.7
Mean Arterial Pressure (mmHg) 76. 6 ± 18.3 72.0 ± 11.0 96.3 ± 13.8* 78.4 ± 12.0*
Central Venous Pressure (mmHg) 11.4 ± 5.8 11.5 ± 4.4 7.9 ± 5.1 8.8 ± 2.1
Urine output (mL/day) 2556.1 ± 918.4 1840.0 ± 1652.8 3705.6 ± 1580.2* 1737.5 ± 1478.9*
FiO2 (%) 59.7 ± 12.4 56.3 ± 20.8 40.6 ± 8.5 46.3 ± 23.4
ScvO2 (%) 73.3 ± 11.6 78.5 ± 7.5 77.1 ± 7.3 77.9 ± 4.5
PvCO2 (mmHg) 46.8 ± 5.7 47.8 ± 4.9 50.6 ± 5.2 46.5 ± 7.8
PaCO2 (mmHg) 42.3 ± 6.3 44.3 ± 6.4 45.3 ± 3.9 41.6 ± 8.3
PvO2 (mmHg) 43.3 ± 4.6 46.5 ± 7.4 44.1 ± 5.9 44.6 ± 5.9
PaO2 (mmHg) 122.2 ± 61.0 98.5 ± 32.0 126.9 ± 29.8 115.1 ± 61.0
PEEP (cmH2O) 8.5 ± 2.5 5.3 ± 5.4 8.9 ± 2.4 8.6 ± 3.4
Lactate (mmol/L) 3.0 ± 1.6 5.0 ± 2.3 1.4 ± 0.5 2.4 ± 2.2
Platelets (×103/mm3) 63.9 ± 35.4 61.4 ± 68.1 112.0 ± 67.2 80.3 ± 50.9
Creatinine (mg/dL) 2.7 ± 0.9 2.1 ± 1.3 1.8 ± 1.7 1.8 ± 1.5
Biluribin (mg/dL) 1.7 ± 0.9 5.0 ± 4.8 1.9 ± 1.3 9.1 ± 10.8
Presepsin (µg/L) 1486 ± 1256 2673 ± 2351 830 ± 458 4969 ± 5826
Renal Repl Therapy (RRT)[no. (%)] 0 (0%) 2 (25%) 1 (11%) 3 (38%)
Ventilatory Support [no. (%)] 9 (100%) 8 (100%) 4 (44%) 7 (88%)
Sofa score
Overall 11.3 ± 2.4 12.4 ± 3.2 5.0 ± 2.1 9.3 ± 5.1
Respiratory System 2.4 ± 1.0 2.4 ± 1.3 1.2 ± 0.8 1.9 ± 1.0
Coagulation 2.3 ± 0.9 2.5 ± 1.4 1.6 ± 1.1 1.9 ± 1.2
Liver 1.1 ± 0.9 1.9 ± 1.2 1.0 ± 1.0 2 ± 1.8
Cardiovascular System 3.6 ± 0.5 3.6 ± 0.5 0.0 ± 0.0 1.1 ± 1.5
Renal System 1.9 ± 0.6 2.0 ± 1.7 1.2 ± 1.5 2.4 ± 1.8

Data are presented as mean ± SD or as frequency. Mean Arterial Pressure and Urine output (marked with *) at D7 were significantly different between the two groups (p-value < 0.05 Wilcoxon rank-sum test).